BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20873879)

  • 1. A pharmacokinetic and pharmacodynamic study of oral oxycodone in a human experimental pain model of hyperalgesia.
    Olesen AE; Upton R; Foster DJ; Staahl C; Christrup LL; Arendt-Nielsen L; Drewes AM
    Clin Pharmacokinet; 2010 Dec; 49(12):817-27. PubMed ID: 20873879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study.
    Olesen AE; Staahl C; Arendt-Nielsen L; Drewes AM
    Br J Clin Pharmacol; 2010 Aug; 70(2):189-200. PubMed ID: 20653672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
    Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
    J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models.
    Andresen T; Upton RN; Foster DJ; Christrup LL; Arendt-Nielsen L; Drewes AM
    Basic Clin Pharmacol Toxicol; 2011 Apr; 108(4):274-84. PubMed ID: 21138531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population pharmacokinetic and pharmacodynamic study of a peripheral κ-opioid receptor agonist CR665 and oxycodone.
    Olesen AE; Kristensen K; Staahl C; Kell S; Wong GY; Arendt-Nielsen L; Drewes AM
    Clin Pharmacokinet; 2013 Feb; 52(2):125-37. PubMed ID: 23212610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic-pharmacodynamic modelling of liquid and controlled-release formulations of oxycodone in healthy volunteers.
    Ladebo L; Foster DJR; Abuhelwa AY; Upton RN; Kongstad KT; Drewes AM; Christrup LL; Olesen AE
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):263-276. PubMed ID: 31597014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study.
    Staahl C; Dimcevski G; Andersen SD; Thorsgaard N; Christrup LL; Arendt-Nielsen L; Drewes AM
    Scand J Gastroenterol; 2007 Mar; 42(3):383-90. PubMed ID: 17354119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain.
    Arendt-Nielsen L; Olesen AE; Staahl C; Menzaghi F; Kell S; Wong GY; Drewes AM
    Anesthesiology; 2009 Sep; 111(3):616-24. PubMed ID: 19672186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.
    Kummer O; Hammann F; Moser C; Schaller O; Drewe J; Krähenbühl S
    Eur J Clin Pharmacol; 2011 Jan; 67(1):63-71. PubMed ID: 20857093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans.
    Babalonis S; Lofwall MR; Nuzzo PA; Walsh SL
    Addict Biol; 2016 Jan; 21(1):146-58. PubMed ID: 25130052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relationship after single oral dose administrations of morphine and oxycodone using laser-evoked potentials on UVB- and capsaicin-irritated skin in healthy male subjects.
    Hoeben E; Smit JW; Upmalis D; Rusch S; Schaffler K; Reitmeir P; Mangold B
    Pain; 2012 Aug; 153(8):1648-1656. PubMed ID: 22703892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Roux-en-Y gastric bypass on the pharmacokinetic-pharmacodynamic relationships of liquid and controlled-release formulations of oxycodone.
    Ladebo L; Abuhelwa AY; Foster DJR; Kroustrup JP; Pacyk GJ; Kongstad KT; Drewes AM; Christrup LL; Olesen AE
    Basic Clin Pharmacol Toxicol; 2021 Sep; 129(3):232-245. PubMed ID: 34228875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of controlled-release opioids.
    Kaiko RF
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):166-74. PubMed ID: 9061102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphisms.
    Olsen R; Foster DJ; Upton RN; Olesen AE; Ross JR; Droney J; Sato H; Drewes AM; Kreilgaard M
    Eur J Pharm Sci; 2016 Apr; 86():41-9. PubMed ID: 26946441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety.
    Samer CF; Daali Y; Wagner M; Hopfgartner G; Eap CB; Rebsamen MC; Rossier MF; Hochstrasser D; Dayer P; Desmeules JA
    Br J Pharmacol; 2010 Jun; 160(4):919-30. PubMed ID: 20590588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir.
    Nieminen TH; Hagelberg NM; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
    Eur J Clin Pharmacol; 2010 Oct; 66(10):977-85. PubMed ID: 20697700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Human Abuse Potential Study of Oxycodone ARIR, a Novel, Immediate-Release, Abuse-Deterrent Formulation.
    Webster LR; Iverson M; Pantaleon C; Smith MD; Kinzler ER; Aigner S
    Pain Med; 2019 Apr; 20(4):747-757. PubMed ID: 29608768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous dextromethorphan to human volunteers: relationship between pharmacokinetics and anti-hyperalgesic effect.
    Duedahl TH; Dirks J; Petersen KB; Romsing J; Larsen NE; Dahl JB
    Pain; 2005 Feb; 113(3):360-368. PubMed ID: 15661445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of telithromycin on the pharmacokinetics and pharmacodynamics of oral oxycodone.
    Grönlund J; Saari T; Hagelberg N; Martikainen IK; Neuvonen PJ; Olkkola KT; Laine K
    J Clin Pharmacol; 2010 Jan; 50(1):101-8. PubMed ID: 19755414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects.
    Eisenberg E; Midbari A; Haddad M; Pud D
    Pain; 2010 Oct; 151(1):104-109. PubMed ID: 20621419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.